Richard E. Schwartz

Partner
Richard E. Schwartz
Boston
+1 617 570 1325

Richard Schwartz is a partner in Goodwin’s Life Sciences group and Public M&A practice. His practice focuses on advising public and private companies on mergers and acquisitions, joint ventures, carve-outs, and other significant transactions. He also advises clients on corporate governance and general corporate matters.

Richard is admitted to practice in New York only.

Experience

Richard’s experience includes advising:

  • Altra Industrial Motion in its $3 billion combination with Fortive’s Automation and & Specialty Platform*
  • Artel in its acquisition by Advanced Instruments, a Patricia Industries company and part of Investor AB*
  • Cano Health shareholders, including members of management, in the $4.4 billion SPAC merger with Jaws Acquisition Corp., including an $800 million PIPE investment*
  • CompoSecure in the spin-off of its subsidiary, Resolute Holdings Management, to form a differentiated alternative asset management platform*
  • CymaBay Therapeutics in its $4.3 billion sale to Gilead Sciences*
  • Exyte in its acquisition of Critical Process Systems Group from Wynnchurch Capital*
  • Forward Air in its amended agreement to acquire Omni Logistics, creating a $3.7 billion company*
  • GasLog Ltd. in its acquisition of GasLog Partners and its take-private transaction with BlackRock’s Global Energy & Power Infrastructure Fund*
  • GreenSky in its $2.2 billion sale to Goldman Sachs*
  • IBM in connection with various transactions, including its sale of healthcare data and analytics assets to Francisco Partners and its acquisition of Octo from Arlington Capital Partners*
  • Lindsay Goldberg and its portfolio companies in connection with various transactions, including the merger of Amentum (jointly controlled with American Securities) with Jacob’s Critical Missions Solutions and Cyber and Intelligence Business and its acquisition of Kleinfelder from Wind Point Partners*
  • Metsera in its $10 billion sale to Pfizer, following a series of competing bids for the company by Pfizer and Novo Nordisk*
  • Noble Corporation in its $2.1 billion acquisition of Diamond Offshore Drilling*
  • Qualcomm in its $2.4 billion acquisition of Alphawave Semi*
  • Radius Global Infrastructure in its $3 billion sale to EQT Active Core Infrastructure and PSP Investments*
  • Resolute Holdings and its affiliates in their acquisition of a majority interest in CompoSecure*
  • Sysco in its pending $29.1 billion acquisition of Jetro Restaurant Depot*

*Denotes experience prior to joining Goodwin

Professional Experience

Prior to joining Goodwin, Richard was a partner in the M&A Group at Paul, Weiss. Previously, Richard was an associate at Cravath, where he advised clients on M&A and securities transactions.

Credentials

Education

JD

Harvard Law School

(cum laude)

AB

Harvard College

(Phi Beta Kappa, summa cum laude)

Admissions

Bars

  • New York